Rony Dahan

Title: Rony Dahan: Innovator in T-Cell Receptor Specificity

Introduction

Rony Dahan is an accomplished inventor based in Mazkeret Batia, Israel. He has made significant contributions to the field of immunology, particularly in the development of high-affinity entities that target specific autoantigens. His work is crucial for advancing diagnostic and therapeutic methods for autoimmune diseases.

Latest Patents

Rony Dahan holds a patent for "Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides." This patent describes isolated complexes that include a major histocompatibility complex (MHC) class II and a type I diabetes-associated GAD autoantigenic peptide. The isolated complex has a structural conformation that allows for the isolation of a high-affinity entity capable of specifically binding to the native conformation of the complex. The patent also details methods and kits for diagnostic and therapeutic applications.

Career Highlights

Rony Dahan is associated with the Technion Research & Development Foundation Limited, where he continues to innovate in the field of immunology. His research focuses on the intersection of T-cell receptor specificity and autoimmune diseases, contributing to the understanding and treatment of conditions like type I diabetes.

Collaborations

Rony Dahan collaborates with Yoram Reiter, enhancing the research and development efforts in their field. Their partnership aims to push the boundaries of current knowledge and technology in immunology.

Conclusion

Rony Dahan's work exemplifies the impact of innovative research in the medical field. His patent and ongoing contributions are paving the way for advancements in diagnostics and therapies for autoimmune diseases.